Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Transplantation|June 10, 2014
B-sides serologic markers of immunogenicity in kidney transplanted patients: report from 2012-2013 flu vaccination experienceStefano Rinaldi, Alberto Cagigi, Veronica Santilli, et al.
Plos One|December 7, 2013
Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)Paolo Palma, Maria Luisa Romiti, Carla Montesano, et al.
Frontiers in Immunology|July 8, 2022
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of TreatmentBeatrice Rivalta, Donato Amodio, Carmela Giancotta, et al.
The Pediatric Infectious Disease Journal|January 13, 2023
Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 VaccinationEmma Concetta Manno, Donato Amodio, Nicola Cotugno, et al.
Frontiers in Immunology|October 30, 2020
Artificial Intelligence Applied to <i>in vitro</i> Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected ChildrenNicola Cotugno, Veronica Santilli, Giuseppe Rubens Pascucci, et al.
Frontiers in Immunology|May 29, 2026
Refractory immune cytopenia successfully treated with mycophenolate mofetil in four adolescents with del22q11.2 syndromeCristina Cifaldi, Lucia Pacillo, Chiara Rossetti, et al.
Clinical Immunology (Orlando, Fla.)|January 7, 2016
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartmentMaria Chiriaco, Immacolata Brigida, Paola Ariganello, et al.
Vaccine|January 11, 2011
The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected childrenPaolo Palma, Maria Luisa Romiti, Giuseppina Li Pira, et al.
Vaccine|February 13, 2025
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups - The CONVERS project, report from a pediatric tertiary hospitalNicola Cotugno, Marco Sanna, Donato Amodio, et al.
Vaccines|September 8, 2015
Immunotherapy with an HIV-DNA Vaccine in Children and AdultsPaolo Palma, Lindvi Gudmundsdotter, Andrea Finocchi, et al.
Pageof 5